HIT Consultant December 30, 2025
Pharmacovigilance (PV) is experiencing a renaissance. Artificial Intelligence (AI) is no longer a futuristic concept in PV; it’s here, reshaping how we manage safety data, detect signals and maintain compliance. From automating case intake to accelerating literature screening and supporting aggregate reporting, AI promises efficiency and scalability at a time when data volumes and regulatory expectations are soaring. Yet, for all its potential, AI introduces a new challenge: trust.
Regulators around the world are raising expectations around transparency, accountability and oversight. These pressures are pushing PV teams to move beyond traditional compliance models and adopt more adaptive, technology-enabled frameworks. To succeed, this shift must balance innovation with responsibility to build a culture in which advanced technology enhances, rather than...
Today's Sponsors
Today's Sponsor